RE 287 (Darcalma hyoscyamine sulfate 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg / sodium phosphate monobasic 40.8 mg)
Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate
Pill imprint RE 287 has been identified as Darcalma hyoscyamine sulfate 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg / sodium phosphate monobasic 40.8 mg.
Darcalma is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darcalma hyoscyamine sulfate 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg / sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- hyoscyamine/methenamine/methylene blue/phenyl salicylate
- Imprint:
- RE 287
- Strength:
- hyoscyamine sulfate 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg / phenyl salicylate 36.2 mg / sodium phosphate monobasic 40.8 mg
- Color:
- Blue
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- River's Edge Pharmaceuticals, LLC
More about Darcalma (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
Consumer resources
- Other brands: Uribel, Hyophen, Phosphasal, Urised, More (8) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
